High Incidence of Undiagnosed Cervical Myelopathy in Patients With Hip Fracture Compared With Controls.
Kristen E Radcliff, Edward P Curry, Roman Trimba...
https://pubmed.ncbi.nlm.nih.gov/26562581Actively Recruiting
Phase Not Applicable
Age: 50Years +
All Genders
ID06893406
Cervical Myelopathy in Hip Fracture Patients Screening and Diagnosis Study
Led by Indiana University · Updated on 2026-05-28
75
Participants Needed
3
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Recent studies have found that many patients who suffer hip fractures from ground level falls may have undiagnosed cervical myelopathy, a condition where the spinal cord in the neck is compressed. This condition can impair balance and coordination, increasing the risk of falls and subsequent fractures. The study aims to screen patients with hip fractures to identify cervical myelopathy and help guide treatment to prevent future falls and fractures. Participants admitted to specific hospitals for hip fractures will undergo a detailed history and physical exam focused on detecting signs of cervical myelopathy. If the exam suggests this condition, patients will be offered a cervical spine MRI as part of their standard care to confirm the diagnosis. Those without signs of cervical myelopathy will not receive further evaluation for this condition during the study. During the hospital stay, study staff will review medical records to confirm eligibility, then perform the examination and history for research purposes. The main outcomes measured include detecting cervical myelopathy through exam and confirming diagnosis by MRI before discharge. The study involves a one-time evaluation at enrollment and follows patients until hospital discharge, with no long-term follow-up mentioned.
CONDITIONS
Brief Title
Cervical Myelopathy in Hip Fracture Patients
Who Can Participate
Age: 50Years +
All Genders
Eligibility Criteria
You may qualify if you...
- Patient admitted to Eskenazi, Methodist, or IU North hospital for a hip fracture caused by a ground level fall
- Hip fracture types include femoral neck, intertrochanteric, subtrochanteric, or pertrochanteric fractures
- Age 50 years or older
You will not qualify if you...
- Neurologic or cognitive disorders explaining the fall, such as dementia, Parkinson's disease, or delirium
- Fall caused by syncope, stroke, or a heart condition
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Your Study Journey
Screening
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) during hospital admission for hip fracture
Diagnostic Evaluation
Duration - During hospital stay until discharge
Participants undergo a history and physical exam to evaluate for signs and symptoms of cervical myelopathy. If signs or symptoms are present, a cervical MRI is scheduled as part of standard care to further assess the diagnosis.
1 to 2 visits depending on initial exam findings
Trial Site Locations
Total: 3 locations
1
Indiana University North Hospital
Fishers, Indiana, United States, 46032
Actively Recruiting
2
Eskenazi Hospital
Indianapolis, Indiana, United States, 46202
Actively Recruiting
3
Indiana University Health Methodist Hospital
Indianapolis, Indiana, United States, 46202
Actively Recruiting
Loading map...
Research Team
Z
Zachary J Gunderson, MD
R
Rowan Flynn, MD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SEQUENTIAL
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here